10-Q Filing

CENCORA, INC. CIK: 1140859 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001140859-21-000045`
Period End Date	20210630
Filing Date	20210804
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	abc-20210630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 88 Cash Flow Statement 86 Stockholders Equity 50 Comprehensive Income 28

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Allowances for returns and credit losses	`AllowancesForReturnsAndDoubtfulAccounts`	$1.32B	USD	Point-in-time
Allowances for returns and credit losses	`AllowancesForReturnsAndDoubtfulAccounts`	$1.42B	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, authorized (shares)	`CommonStockSharesAuthorized`	600.00M	shares	Point-in-time
Common stock, authorized (shares)	`CommonStockSharesAuthorized`	600.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.55B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.60B	USD	Point-in-time
Accounts receivable, less allowances for returns and credit losses: $1,320,465 as of June 30, 2021 and $1,417,308 as of September 30, 2020	`AccountsReceivableNetCurrent`	$17.70B	USD	Point-in-time
Accounts receivable, less allowances for returns and credit losses: $1,320,465 as of June 30, 2021 and $1,417,308 as of September 30, 2020	`AccountsReceivableNetCurrent`	$13.85B	USD	Point-in-time
Common stock, issued (shares)	`CommonStockSharesIssued`	290.34M	shares	Point-in-time
Common stock, issued (shares)	`CommonStockSharesIssued`	287.79M	shares	Point-in-time
Common stock, outstanding (shares)	`CommonStockSharesOutstanding`	207.71M	shares	Point-in-time
Common stock, outstanding (shares)	`CommonStockSharesOutstanding`	204.23M	shares	Point-in-time
Inventories	`InventoryNet`	$12.59B	USD	Point-in-time
Inventories	`InventoryNet`	$15.00B	USD	Point-in-time
Right to recover assets	`ContractWithCustomerAssetGrossCurrent`	$1.34B	USD	Point-in-time
Treasury stock (shares)	`TreasuryStockShares`	82.63M	shares	Point-in-time
Treasury stock (shares)	`TreasuryStockShares`	83.56M	shares	Point-in-time
Right to recover assets	`ContractWithCustomerAssetGrossCurrent`	$1.22B	USD	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$488.43M	USD	Point-in-time
Income tax receivable	`IncomeTaxesReceivable`	$254.06M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$189.30M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$545.11M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$33.06B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$37.26B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.48B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.14B	USD	Point-in-time
Goodwill	`Goodwill`	$6.71B	USD	Point-in-time
Goodwill	`Goodwill`	$9.13B	USD	Point-in-time
Other intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$5.44B	USD	Point-in-time
Other intangible assets	`IntangibleAssetsNetExcludingGoodwill`	$1.89B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$289.04M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$361.64M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.67B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$779.85M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$44.27B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$55.93B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$31.71B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$36.50B	USD	Point-in-time
Accrued expenses and other	`AccruedLiabilitiesCurrent`	$2.63B	USD	Point-in-time
Accrued expenses and other	`AccruedLiabilitiesCurrent`	$1.65B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$501.26M	USD	Point-in-time
Short-term debt	`DebtCurrent`	$455.61M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$33.85B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$39.59B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$6.65B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$3.62B	USD	Point-in-time
Accrued income taxes	`AccruedIncomeTaxesNoncurrent`	$283.74M	USD	Point-in-time
Accrued income taxes	`AccruedIncomeTaxesNoncurrent`	$284.85M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$686.49M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$1.67B	USD	Point-in-time
Accrued litigation liability	`LitigationReserveNoncurrent`	$6.20B	USD	Point-in-time
Accrued litigation liability	`LitigationReserveNoncurrent`	$6.27B	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$472.86M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$1.06B	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value - authorized, issued, and outstanding: 600,000,000 shares, 290,343,806 shares, and 207,710,721 shares as of June 30, 2021, respectively, and 600,000,000 shares, 287,790,479 shares, and 204,226,465 shares as of September 30, 2020, respectively	`CommonStockValue`	$2.90M	USD	Point-in-time
Common stock, $0.01 par value - authorized, issued, and outstanding: 600,000,000 shares, 290,343,806 shares, and 207,710,721 shares as of June 30, 2021, respectively, and 600,000,000 shares, 287,790,479 shares, and 204,226,465 shares as of September 30, 2020, respectively	`CommonStockValue`	$2.88M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.41B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.08B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$518.34M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.33B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-233.24M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-108.83M	USD	Point-in-time
Treasury stock, at cost: 82,633,085 shares as of June 30, 2021 and 83,564,014 shares as of September 30, 2020	`TreasuryStockValue`	$6.47B	USD	Point-in-time
Treasury stock, at cost: 82,633,085 shares as of June 30, 2021 and 83,564,014 shares as of September 30, 2020	`TreasuryStockValue`	$6.51B	USD	Point-in-time
Total AmerisourceBergen Corporation stockholders' equity (deficit)	`StockholdersEquity`	$-1.02B	USD	Point-in-time
Total AmerisourceBergen Corporation stockholders' equity (deficit)	`StockholdersEquity`	$37.96M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$179.29M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$370.48M	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.97B	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.99B	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$408.44M	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-102.78M	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-839.64M	USD	Point-in-time
Total equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.71B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$55.93B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$44.27B	USD	Point-in-time

Income Statement 88 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$140.65B	USD	3 Qtrs
Revenue	`Revenues`	$53.41B	USD	1 Quarter
Revenue	`Revenues`	$155.08B	USD	3 Qtrs
Revenue	`Revenues`	$45.37B	USD	1 Quarter
Cost of goods sold	`CostOfGoodsAndServicesSold`	$51.52B	USD	1 Quarter
Cost of goods sold	`CostOfGoodsAndServicesSold`	$136.80B	USD	3 Qtrs
Cost of goods sold	`CostOfGoodsAndServicesSold`	$150.20B	USD	3 Qtrs
Cost of goods sold	`CostOfGoodsAndServicesSold`	$44.14B	USD	1 Quarter
Gross profit	`GrossProfit`	$1.23B	USD	1 Quarter
Gross profit	`GrossProfit`	$3.85B	USD	3 Qtrs
Gross profit	`GrossProfit`	$4.87B	USD	3 Qtrs
Gross profit	`GrossProfit`	$1.89B	USD	1 Quarter
Distribution, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$913.41M	USD	1 Quarter
Distribution, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$2.38B	USD	3 Qtrs
Distribution, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$666.88M	USD	1 Quarter
Distribution, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$2.05B	USD	3 Qtrs
Depreciation	`DepreciationNonproduction`	$231.53M	USD	3 Qtrs
Depreciation	`DepreciationNonproduction`	$208.63M	USD	3 Qtrs
Depreciation	`DepreciationNonproduction`	$69.59M	USD	1 Quarter
Depreciation	`DepreciationNonproduction`	$82.32M	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$85.09M	USD	3 Qtrs
Amortization	`AmortizationOfIntangibleAssets`	$44.78M	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$25.82M	USD	1 Quarter
Amortization	`AmortizationOfIntangibleAssets`	$95.92M	USD	3 Qtrs
Employee severance, litigation, and other	`RestructuringCharges`	$58.59M	USD	1 Quarter
Employee severance, litigation, and other	`RestructuringCharges`	$375.50M	USD	3 Qtrs
Employee severance, litigation, and other	`RestructuringCharges`	$165.63M	USD	3 Qtrs
Employee severance, litigation, and other	`RestructuringCharges`	$226.96M	USD	1 Quarter
Impairment of PharMEDium assets	`AssetImpairmentCharges`	$361.65M	USD	3 Qtrs
Impairment of PharMEDium assets	`AssetImpairmentCharges`	-	USD	1 Quarter
Impairment of PharMEDium assets	`AssetImpairmentCharges`	-	USD	1 Quarter
Impairment of PharMEDium assets	`AssetImpairmentCharges`	-	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$977.78M	USD	3 Qtrs
Operating income	`OperatingIncomeLoss`	$620.73M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$404.83M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$1.79B	USD	3 Qtrs
Other (income) loss, net	`NonoperatingIncomeExpense`	$-1.07M	USD	1 Quarter
Other (income) loss, net	`NonoperatingIncomeExpense`	$-4.90M	USD	3 Qtrs
Other (income) loss, net	`NonoperatingIncomeExpense`	$-2.81M	USD	3 Qtrs
Other (income) loss, net	`NonoperatingIncomeExpense`	$4.14M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-103.18M	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-51.34M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-119.48M	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-37.75M	USD	1 Quarter
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	$-22.18M	USD	1 Quarter
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	$-22.18M	USD	3 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$343.83M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$849.63M	USD	3 Qtrs
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$573.53M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.67B	USD	3 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-595.32M	USD	3 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$278.08M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$56.57M	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$559.76M	USD	3 Qtrs
Net income	`ProfitLoss`	$1.11B	USD	3 Qtrs
Net income	`ProfitLoss`	$287.27M	USD	1 Quarter
Net income	`ProfitLoss`	$1.44B	USD	3 Qtrs
Net income	`ProfitLoss`	$295.45M	USD	1 Quarter
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.93M	USD	3 Qtrs
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-2.17M	USD	1 Quarter
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$7.59M	USD	3 Qtrs
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$3.33M	USD	1 Quarter
Net income attributable to AmerisourceBergen Corporation	`NetIncomeLoss`	$292.12M	USD	1 Quarter
Net income attributable to AmerisourceBergen Corporation	`NetIncomeLoss`	$289.44M	USD	1 Quarter
Net income attributable to AmerisourceBergen Corporation	`NetIncomeLoss`	$1.44B	USD	3 Qtrs
Net income attributable to AmerisourceBergen Corporation	`NetIncomeLoss`	$1.10B	USD	3 Qtrs
Basic (usd per share)	`EarningsPerShareBasic`	$1.42	USD	1 Quarter
Basic (usd per share)	`EarningsPerShareBasic`	$1.42	USD	1 Quarter
Basic (usd per share)	`EarningsPerShareBasic`	$5.37	USD	3 Qtrs
Basic (usd per share)	`EarningsPerShareBasic`	$7.01	USD	3 Qtrs
Diluted (usd per share)	`EarningsPerShareDiluted`	$5.31	USD	3 Qtrs
Diluted (usd per share)	`EarningsPerShareDiluted`	$6.95	USD	3 Qtrs
Diluted (usd per share)	`EarningsPerShareDiluted`	$1.40	USD	1 Quarter
Diluted (usd per share)	`EarningsPerShareDiluted`	$1.41	USD	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	203.65M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	205.02M	shares	3 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	205.25M	shares	3 Qtrs
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	206.16M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	206.71M	shares	3 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	205.54M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	207.68M	shares	3 Qtrs
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	208.91M	shares	1 Quarter
Cash dividends declared per share of common stock (usd per share)	`CommonStockDividendsPerShareDeclared`	$1.24	USD	3 Qtrs
Cash dividends declared per share of common stock (usd per share)	`CommonStockDividendsPerShareDeclared`	$0.42	USD	1 Quarter
Cash dividends declared per share of common stock (usd per share)	`CommonStockDividendsPerShareDeclared`	$0.44	USD	1 Quarter
Cash dividends declared per share of common stock (usd per share)	`CommonStockDividendsPerShareDeclared`	$1.32	USD	3 Qtrs

Cash Flow Statement 86 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$1.11B	USD	3 Qtrs
Net income	`ProfitLoss`	$287.27M	USD	1 Quarter
Net income	`ProfitLoss`	$1.44B	USD	3 Qtrs
Net income	`ProfitLoss`	$295.45M	USD	1 Quarter
Depreciation, including amounts charged to cost of goods sold	`Depreciation`	$237.85M	USD	3 Qtrs
Depreciation, including amounts charged to cost of goods sold	`Depreciation`	$215.19M	USD	3 Qtrs
Amortization, including amounts charged to interest expense	`AdjustmentForAmortization`	$93.76M	USD	3 Qtrs
Amortization, including amounts charged to interest expense	`AdjustmentForAmortization`	$102.64M	USD	3 Qtrs
Provision for credit losses	`ProvisionForDoubtfulAccounts`	$25.41M	USD	3 Qtrs
Provision for credit losses	`ProvisionForDoubtfulAccounts`	$13.53M	USD	3 Qtrs
Provision (benefit) for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-7.20M	USD	3 Qtrs
Provision (benefit) for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$303.64M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$81.47M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$57.58M	USD	3 Qtrs
LIFO (credit) expense	`InventoryLIFOReservePeriodCharge`	$-160.56M	USD	3 Qtrs
LIFO (credit) expense	`InventoryLIFOReservePeriodCharge`	$43.20M	USD	3 Qtrs
Impairment of PharMEDium assets	`AssetImpairmentCharges`	$361.65M	USD	3 Qtrs
Impairment of PharMEDium assets	`AssetImpairmentCharges`	-	USD	1 Quarter
Impairment of PharMEDium assets	`AssetImpairmentCharges`	-	USD	1 Quarter
Impairment of PharMEDium assets	`AssetImpairmentCharges`	-	USD	3 Qtrs
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	$-22.18M	USD	1 Quarter
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Loss on early retirement of debt	`GainsLossesOnExtinguishmentOfDebt`	$-22.18M	USD	3 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$-10.24M	USD	3 Qtrs
Other, net	`OtherNoncashIncomeExpense`	$-21.39M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$436.24M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$116.84M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$910.83M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$594.71M	USD	3 Qtrs
Income taxes receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$590.16M	USD	3 Qtrs
Income taxes receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$-234.36M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-86.54M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-28.76M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$824.11M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$242.42M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-44.79M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-97.09M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-177.68M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$69.35M	USD	3 Qtrs
Long-term accrued litigation liability	`IncreaseDecreaseInAccruedEstimatedLitigationLiability`	-	USD	3 Qtrs
Long-term accrued litigation liability	`IncreaseDecreaseInAccruedEstimatedLitigationLiability`	$72.33M	USD	3 Qtrs
NET CASH PROVIDED BY OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$1.66B	USD	3 Qtrs
NET CASH PROVIDED BY OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$907.81M	USD	3 Qtrs
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$273.41M	USD	3 Qtrs
Capital expenditures	`PaymentsToAcquirePropertyPlantAndEquipment`	$251.10M	USD	3 Qtrs
Cost of acquired companies, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Cost of acquired companies, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$5.54B	USD	3 Qtrs
Cost of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$162.62M	USD	3 Qtrs
Cost of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$34.83M	USD	3 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-7.82M	USD	3 Qtrs
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-2.52M	USD	3 Qtrs
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-278.11M	USD	3 Qtrs
NET CASH USED IN INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-5.97B	USD	3 Qtrs
Senior notes and other loan borrowings	`ProceedsFromIssuanceOfDebt`	$590.11M	USD	3 Qtrs
Senior notes and other loan borrowings	`ProceedsFromIssuanceOfDebt`	$3.17B	USD	3 Qtrs
Loan repayments	`RepaymentsOfLongTermDebt`	$550.35M	USD	3 Qtrs
Loan repayments	`RepaymentsOfLongTermDebt`	$568.03M	USD	3 Qtrs
Borrowings under revolving and securitization credit facilities	`ProceedsFromLinesOfCredit`	$116.95M	USD	3 Qtrs
Borrowings under revolving and securitization credit facilities	`ProceedsFromLinesOfCredit`	$4.62B	USD	3 Qtrs
Repayments under revolving and securitization credit facilities	`RepaymentsOfLinesOfCredit`	$149.98M	USD	3 Qtrs
Repayments under revolving and securitization credit facilities	`RepaymentsOfLinesOfCredit`	$4.61B	USD	3 Qtrs
Payment of premium on early retirement of debt	`PaymentsOfDebtExtinguishmentCosts`	-	USD	3 Qtrs
Payment of premium on early retirement of debt	`PaymentsOfDebtExtinguishmentCosts`	$21.45M	USD	3 Qtrs
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$420.45M	USD	3 Qtrs
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$82.15M	USD	3 Qtrs
Exercises of stock options	`ProceedsFromStockOptionsExercised`	$164.30M	USD	3 Qtrs
Exercises of stock options	`ProceedsFromStockOptionsExercised`	$137.75M	USD	3 Qtrs
Cash dividends on common stock	`PaymentsOfDividendsCommonStock`	$256.76M	USD	3 Qtrs
Cash dividends on common stock	`PaymentsOfDividendsCommonStock`	$274.04M	USD	3 Qtrs
Tax withholdings related to restricted share vesting	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$23.53M	USD	3 Qtrs
Tax withholdings related to restricted share vesting	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$9.66M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-2.09M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-7.43M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$-583.62M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$2.40B	USD	3 Qtrs
(DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.92B	USD	3 Qtrs
(DECREASE) INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$46.08M	USD	3 Qtrs
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.68B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.42B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.37B	USD	Point-in-time
Cash, cash equivalents, and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.60B	USD	Point-in-time
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.68B	USD	Point-in-time
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.42B	USD	Point-in-time
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.37B	USD	Point-in-time
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.60B	USD	Point-in-time

Stockholders Equity 50 line items

Line Item	Tag	Value	Unit	Period
Cash dividends (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$1.32	USD	3 Qtrs
Cash dividends (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$0.44	USD	1 Quarter
Cash dividends (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$1.24	USD	3 Qtrs
Cash dividends (in dollars per share)	`CommonStockDividendsPerShareCashPaid`	$0.42	USD	1 Quarter
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.97B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.99B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$408.44M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-102.78M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-839.64M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.71B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$1.11B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$287.27M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.44B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$295.45M	USD	1 Quarter
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-154.07M	USD	1 Quarter
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$2.49M	USD	1 Quarter
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-27.88M	USD	3 Qtrs
Other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-114.14M	USD	3 Qtrs
Cash dividends	`DividendsCommonStockCash`	$86.22M	USD	1 Quarter
Cash dividends	`DividendsCommonStockCash`	$256.76M	USD	3 Qtrs
Cash dividends	`DividendsCommonStockCash`	$274.04M	USD	3 Qtrs
Cash dividends	`DividendsCommonStockCash`	$91.68M	USD	1 Quarter
Exercises of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$60.99M	USD	1 Quarter
Exercises of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$33.97M	USD	1 Quarter
Exercises of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$137.75M	USD	3 Qtrs
Exercises of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$164.30M	USD	3 Qtrs
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$57.58M	USD	3 Qtrs
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$81.47M	USD	3 Qtrs
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.36M	USD	1 Quarter
Share-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.82M	USD	1 Quarter
Equity consideration issued for acquisition of Alliance Healthcare (Note 2)	`StockIssuedDuringPeriodValueAcquisitions`	$235.14M	USD	3 Qtrs
Equity consideration issued for acquisition of Alliance Healthcare (Note 2)	`StockIssuedDuringPeriodValueAcquisitions`	$235.14M	USD	1 Quarter
Acquisition of Alliance Healthcare (Note 2)	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$178.26M	USD	1 Quarter
Acquisition of Alliance Healthcare (Note 2)	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$178.26M	USD	3 Qtrs
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$405.69M	USD	3 Qtrs
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$82.15M	USD	3 Qtrs
Purchases of common stock	`TreasuryStockValueAcquiredCostMethod`	$13.30M	USD	1 Quarter
Employee tax withholdings related to restricted share vesting	`EmployeeTaxWithholdingsRelatedToRestrictedShareVesting`	$9.66M	USD	3 Qtrs
Employee tax withholdings related to restricted share vesting	`EmployeeTaxWithholdingsRelatedToRestrictedShareVesting`	$75.00K	USD	1 Quarter
Employee tax withholdings related to restricted share vesting	`EmployeeTaxWithholdingsRelatedToRestrictedShareVesting`	$23.53M	USD	3 Qtrs
Other	`StockholdersEquityOther`	$1.30M	USD	3 Qtrs
Other	`StockholdersEquityOther`	$205.00K	USD	1 Quarter
Other	`StockholdersEquityOther`	$133.00K	USD	1 Quarter
Other	`StockholdersEquityOther`	$671.00K	USD	3 Qtrs
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.97B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.99B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$408.44M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-102.78M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-839.64M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$3.71B	USD	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$1.11B	USD	3 Qtrs
Net income	`ProfitLoss`	$287.27M	USD	1 Quarter
Net income	`ProfitLoss`	$1.44B	USD	3 Qtrs
Net income	`ProfitLoss`	$295.45M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-154.07M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-114.14M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$3.18M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-27.22M	USD	3 Qtrs
Other	`OtherComprehensiveIncomeOtherNetOfTax`	-	USD	1 Quarter
Other	`OtherComprehensiveIncomeOtherNetOfTax`	$-656.00K	USD	3 Qtrs
Other	`OtherComprehensiveIncomeOtherNetOfTax`	$-690.00K	USD	1 Quarter
Other	`OtherComprehensiveIncomeOtherNetOfTax`	-	USD	3 Qtrs
Total other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-154.07M	USD	1 Quarter
Total other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$2.49M	USD	1 Quarter
Total other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-27.88M	USD	3 Qtrs
Total other comprehensive (loss) income	`OtherComprehensiveIncomeLossNetOfTax`	$-114.14M	USD	3 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$994.02M	USD	3 Qtrs
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$289.76M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$141.37M	USD	1 Quarter
Total comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.42B	USD	3 Qtrs
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$13.24M	USD	1 Quarter
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$16.20M	USD	3 Qtrs
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-3.82M	USD	1 Quarter
Comprehensive (income) loss attributable to noncontrolling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-3.59M	USD	3 Qtrs
Comprehensive income attributable to AmerisourceBergen Corporation	`ComprehensiveIncomeNetOfTax`	$1.42B	USD	3 Qtrs
Comprehensive income attributable to AmerisourceBergen Corporation	`ComprehensiveIncomeNetOfTax`	$293.58M	USD	1 Quarter
Comprehensive income attributable to AmerisourceBergen Corporation	`ComprehensiveIncomeNetOfTax`	$128.13M	USD	1 Quarter
Comprehensive income attributable to AmerisourceBergen Corporation	`ComprehensiveIncomeNetOfTax`	$977.83M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.